Search research articles
Contact Us
Filters
Showing results (11-20 of 21) with videos related to
Page
of 3
Sort By:
Brain Communications
|
March 10, 2022
Astrocytic junctional adhesion molecule-A regulates T-cell entry past the glia limitans to promote central nervous system autoimmune attack
Mario Amatruda, Candice Chapouly, Viola Woo, et al.
Journal of Neuroinflammation
|
October 10, 2024
Astrocytic DLL4-NOTCH1 signaling pathway promotes neuroinflammation via the IL-6-STAT3 axis
Pierre Mora, Margaux Laisné, Célia Bourguignon, et al.
Plos Biology
|
November 30, 2020
Blood-brain barrier genetic disruption leads to protective barrier formation at the Glia Limitans
Pierre Mora, Pierre-Louis Hollier, Sarah Guimbal, et al.
Multiple Sclerosis and Related Disorders
|
May 9, 2022
Differential antibody response to COVID-19 vaccines across immunomodulatory therapies for multiple sclerosis
Sammita Satyanarayan, Neha Safi, Tali Sorets, et al.
Annals of Clinical and Translational Neurology
|
May 5, 2021
Sleep disturbance and memory dysfunction in early multiple sclerosis
James F Sumowski, Sam Horng, Rachel Brandstadter, et al.
Brain : a Journal of Neurology
|
March 26, 2015
Astrocytic TYMP and VEGFA drive blood-brain barrier opening in inflammatory central nervous system lesions
Candice Chapouly, Azeb Tadesse Argaw, Sam Horng, et al.
The Journal of Clinical Investigation
|
July 25, 2017
Astrocytic tight junctions control inflammatory CNS lesion pathogenesis
Sam Horng, Anthony Therattil, Sarah Moyon, et al.
Multiple Sclerosis and Related Disorders
|
January 11, 2023
Evaluation of immunological responses to third COVID-19 vaccine among people treated with sphingosine receptor-1 modulators and anti-CD20 therapy
Ilana Katz Sand, Sacha Gnjatic, Florian Krammer, et al.
Medrxiv : the Preprint Server for Health Sciences
|
June 23, 2022
Evaluation of immunological responses to third COVID-19 vaccine among people treated with sphingosine receptor-1 modulators and anti-CD20 therapy
Ilana Katz Sand, Sacha Gnjatic, Florian Krammer, et al.
Plos Biology
|
May 24, 2016
The Transcriptional Activator Krüppel-like Factor-6 Is Required for CNS Myelination
Benjamin M Laitman, Linnéa Asp, John N Mariani, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 21) with videos related to
Sort By:
Page
of 3
Brain Communications
|
March 10, 2022
Astrocytic junctional adhesion molecule-A regulates T-cell entry past the glia limitans to promote central nervous system autoimmune attack
Mario Amatruda, Candice Chapouly, Viola Woo, et al.
Journal of Neuroinflammation
|
October 10, 2024
Astrocytic DLL4-NOTCH1 signaling pathway promotes neuroinflammation via the IL-6-STAT3 axis
Pierre Mora, Margaux Laisné, Célia Bourguignon, et al.
Plos Biology
|
November 30, 2020
Blood-brain barrier genetic disruption leads to protective barrier formation at the Glia Limitans
Pierre Mora, Pierre-Louis Hollier, Sarah Guimbal, et al.
Multiple Sclerosis and Related Disorders
|
May 9, 2022
Differential antibody response to COVID-19 vaccines across immunomodulatory therapies for multiple sclerosis
Sammita Satyanarayan, Neha Safi, Tali Sorets, et al.
Annals of Clinical and Translational Neurology
|
May 5, 2021
Sleep disturbance and memory dysfunction in early multiple sclerosis
James F Sumowski, Sam Horng, Rachel Brandstadter, et al.
Brain : a Journal of Neurology
|
March 26, 2015
Astrocytic TYMP and VEGFA drive blood-brain barrier opening in inflammatory central nervous system lesions
Candice Chapouly, Azeb Tadesse Argaw, Sam Horng, et al.
The Journal of Clinical Investigation
|
July 25, 2017
Astrocytic tight junctions control inflammatory CNS lesion pathogenesis
Sam Horng, Anthony Therattil, Sarah Moyon, et al.
Multiple Sclerosis and Related Disorders
|
January 11, 2023
Evaluation of immunological responses to third COVID-19 vaccine among people treated with sphingosine receptor-1 modulators and anti-CD20 therapy
Ilana Katz Sand, Sacha Gnjatic, Florian Krammer, et al.
Medrxiv : the Preprint Server for Health Sciences
|
June 23, 2022
Evaluation of immunological responses to third COVID-19 vaccine among people treated with sphingosine receptor-1 modulators and anti-CD20 therapy
Ilana Katz Sand, Sacha Gnjatic, Florian Krammer, et al.
Plos Biology
|
May 24, 2016
The Transcriptional Activator Krüppel-like Factor-6 Is Required for CNS Myelination
Benjamin M Laitman, Linnéa Asp, John N Mariani, et al.
Page
of 3